-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WmyirTPRmSU5Ry5v6sWbv+VD2paHux0mG4N2eYp53SVeBYtMB7zrV3Gg394XpfcA fuicpqHY7jlHlHQYTYzqsQ== 0000102198-03-000021.txt : 20031031 0000102198-03-000021.hdr.sgml : 20031031 20031031134342 ACCESSION NUMBER: 0000102198-03-000021 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20031029 ITEM INFORMATION: FILED AS OF DATE: 20031031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COMPETITIVE TECHNOLOGIES INC CENTRAL INDEX KEY: 0000102198 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 362664428 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08696 FILM NUMBER: 03969226 BUSINESS ADDRESS: STREET 1: 1960 BRONSON ROAD STREET 2: BUILDING 1 CITY: FAIRFIELD STATE: CT ZIP: 06824 BUSINESS PHONE: 2032556044 MAIL ADDRESS: STREET 1: 1960 BRONSON ROAD STREET 2: BUILDING 1 CITY: FAIRFIELD STATE: CT ZIP: 06824 FORMER COMPANY: FORMER CONFORMED NAME: UNIVERSITY PATENTS INC DATE OF NAME CHANGE: 19920703 8-K 1 f8k1029.txt FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 29, 2003 COMPETITIVE TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 1-8696 36-2664428 (State or other (Commission File (IRS Employer jurisdiction Number) Identification No. of incorporation) 1960 Bronson Road, Fairfield, Connecticut 06824 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (203) 255-6044 Item 12. Results of Operations and Financial Condition. On October 29, 2003, Competitive Technologies, Inc. (CTT) announced its fiscal results for the quarter and fiscal year ended July 31, 2003. A copy of CTT's press release is attached hereto as Exhibit 99.1. The information in this Current Report on Form 8-K and the attached exhibit is furnished pursuant to Item 12 and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COMPETITIVE TECHNOLOGIES, INC. Registrant Date: October 31, 2003 /s/ John B. Nano By: John B. Nano President, Chief Executive Officer and Authorized Signer Exhibit Index 99.1 Press release dated October 29, 2003. 3-5 EX-99.1 4 ex99-1.txt PRESS RELEASE YEAR ENDED JULY 31, 2003 Exhibit 99.1 For Immediate Release: COMPETITIVE TECHNOLOGIES REPORTS RESULTS FOR FISCAL YEAR ENDED JULY 31, 2003 Fairfield, CT - (October 29, 2003) - Competitive Technologies, Inc. (AMEX: CTT) today announced its results for the 2003 fiscal fourth quarter and year ended July 31, 2003. Revenues for fiscal 2003 increased 27% to $3.3 million compared with $2.6 million for fiscal 2002. CTT revenues for the fourth quarter of fiscal 2003 increased 69% to $1.4 million compared with $0.8 million in the fourth quarter of fiscal 2002. Revenues in the fourth quarter of fiscal 2003 include $0.6 million from CTT's sale of $1.3 million of its potential award in the Materna litigation. CTT's net loss for fiscal 2003 declined 52% to $1.9 million, compared with the net loss for fiscal 2002 of $4.0 million. The net loss for the fourth quarter of fiscal 2003 of $0.76 million was primarily due to impairment charges on the ribozyme technology and financing expenses, compared with a net loss of $0.78 million for the fourth quarter of fiscal 2002. "The results for 2003 show improvement, but are still not acceptable," said John B. Nano, CTT's President and CEO. "Our plan to profitably unlock the potential of innovation by focusing on attractive global market opportunities is progressing, even with the need to address some unexpected difficulties." Mr. Nano continued, "In February 2003, financing activities were initiated to raise an additional $5 million in funding. Due to a difficult financing market and the SEC investigation into the company's 1998 stock buy-back program, funding was not obtained. CTT had anticipated collecting $6 million from its successful litigation against Wyeth, which has been delayed by Wyeth's third appeal of a federal court's decision. Either the funding plan or the litigation award would have substantially reinforced CTT's financial strength. However, our auditors' opinion includes an explanatory paragraph about our ability to continue as a going- concern. Nevertheless, in fiscal 2004 we expect to realize potential financial infusions into the company through new licensing agreements, litigation awards and/or funding which will enable us to successfully implement our business plan." "In 2003, we positioned CTT for growth and profitability by focusing operating resources on building a new team to proactively market our technology versus leading expensive patent enforcement actions and making direct investments to develop technologies. Over the last two years, asset impairments and write-offs from these direct investments have reduced our shareholder equity and asset balances approximately $2.4 million. During the past several months, significant accomplishments were achieved in rebuilding CTT's competitive advantage including: acquiring new technologies from universities and world renowned laboratories; licensing technologies to prestigious companies; forming important strategic alliances reaching hundreds of potential customers; and receiving favorable federal court judgments against both LabCorp (NYSE: LH) and Wyeth (NYSE: WYE)." About Competitive Technologies, Inc. Competitive Technologies, established in 1968, is a full service technology transfer and licensing provider focused on the technology needs of its customers and transforming those requirements into commercially viable solutions. CTT is a global leader in identifying, developing and commercializing innovative technologies in life, digital, nano, and physical sciences developed by universities, companies and inventors. The global market for technology transfer services is estimated at $150 billion annually. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTT's website: http://www.competitivetech.net Statements about the Company's future expectations, including development and regulatory plans, and all other statements in this document other than historical facts are "forward-looking statements" within the meaning of applicable Federal Securities Laws and are not guarantees of future performance. These statements involve risks and uncertainties, including those set forth in Item 1 of the Company's most recent Form 10-K and in CTT's other filings with the SEC, and are subject to change at any time. The Company's actual results could differ materially from these forward-looking statements. The Company undertakes no obligation to update publicly any forward-looking statement. Direct inquiries to: Johnnie D. Johnson, Strategic IR, Inc. E-mail: jdjohnson@strategic-ir.com Tel. (212) 754-6565; Fax (212) 754-4333 E-mail: ctt@competitivetech.net COMPETITIVE TECHNOLOGIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED RESULTS OF OPERATIONS (dollars in thousands, except per share amounts) Fourth Quarter Ended Fiscal Year Ended July 31 July 31 2003 2002 2003 2002 Revenue $ 1,419 $ 842 $ 3,293 $ 2,596 Total operating expense 2,181 1,372 4,311 5,875 Operating loss $ (762) $ (530) $ (1,018) $ (3,279) Net loss $ (759) $ (778) $ (1,935) $ (4,016) Net loss per share: Basic and diluted $ (0.12) $ (0.13) $ (0.31) $ (0.65) Weighted average number of common shares outstanding: Basic and diluted (000) 6,201 6,154 6,183 6,148 Other Financial Data Cash and cash equivalents $ 1,405 $ 750 Short-term investments $ 100 $ 2,137 Total assets $ 2,953 $ 6,400 Total liabilities $ 1,783 $ 3,407 Shareholders' equity $ 1,169 $ 2,993 -----END PRIVACY-ENHANCED MESSAGE-----